ENTITY

TuHURA Biosciences (HURA US)

5
Analysis
Health Care • United States
TuHURA Biosciences, Inc. is a phase 3 registration-stage immuno-oncology company. The Company focuses on developing technologies to overcome resistance to cancer immunotherapy. TuHURA Biosciences operates in the United States.
more
Exchange Announcement • 06 Dec 2025 06:00
Exchange Announcement • 25 Nov 2025 21:01
Exchange Announcement • 25 Nov 2025 21:00
Exchange Announcement • 19 Nov 2025 06:03
Exchange Announcement • 14 Nov 2025 20:20
x